HIMS & HERS HEALTH $HIMS JUST REPORTED Q2 EARNINGS
- EPS loss of $0.37 missing expectations of a $0.03 loss ๐ด (compared with a profit of $0.17 in the same period last year)
- Revenue of $753.214M beating expectations of $699.889M ๐ข (up 38.25% YoY)
- Gross margin of 64%, down from 76% in the same period last year
- Net loss of $86.3M, compared with net income of $42.5M in the same period last year
- Subscribers grew to nearly 2.9 million, up 19% YoY
International revenue grew more than 17-fold following the close of the Eucalyptus acquisition in June. Domestic revenue growth accelerated to 16% YoY.
Company raised full-year 2026 guidance: revenue of $3.1B-$3.3B, Adjusted EBITDA of $275M-$325M
๋ ๋ณด๊ธฐ
